Well, that's a very good question. It's a question I asked myself when I observed that too. I thought I should check the patent status of those drugs in both Canada and the United States. What I discovered was that 50% of the sales value of generic drugs going through the border to the United States was of products that were generically available here but still under active patent protection in the United States, with representative savings of sorts to consumers who were buying them. But this also represents an enormous rip-off of intellectual property that I think threatens our trading relationships.
On June 20th, 2006. See this statement in context.